News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
195 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (28807)
Month
January (2935)
February (2968)
March (2707)
April (2905)
May (3623)
June (2409)
July (2086)
August (2588)
September (2381)
October (3062)
November (1143)
Day
1 (86)
3 (15)
4 (48)
5 (127)
6 (193)
7 (194)
8 (195)
9 (1)
11 (65)
12 (179)
13 (158)
14 (111)
15 (154)
18 (92)
19 (92)
20 (119)
21 (99)
22 (68)
24 (15)
25 (85)
26 (125)
27 (76)
28 (174)
29 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
3
4
5
6
7
8
9
11
12
13
14
15
18
19
20
21
22
24
25
26
27
28
29
Layoffs
Dewpoint Slashes Headcount by 70% as Cash Runway Runs Out
In December 2024, Dewpoint Therapeutics CEO Ameet Nathwani said the biotech’s cash runway would last until the third quarter of 2025.
August 8, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
FDA Launches New PreCheck Program to Lower Regulatory Barriers to Pharma Manufacturing
Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.
August 8, 2025
·
2 min read
·
Tristan Manalac
Earnings
Gilead Confident in PrEP Franchise Even Amid Preventive Task Force Uncertainties
The U.S. Preventive Services Task Force makes recommendations for preventive services—including Gilead’s twice-yearly HIV PrEP Yeztugo—that insurers must cover. A recently postponed meeting has raised concerns that Health Secretary RFK Jr. could abolish or overhaul the group.
August 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update
August 8, 2025
·
12 min read
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Press Releases
BioVie Inc. Announces Pricing of $12 Million Public Offering
August 8, 2025
·
5 min read
Press Releases
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2025
August 8, 2025
·
1 min read
Press Releases
Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering
August 8, 2025
·
2 min read
Press Releases
Quanterix Releases Financial Results for the Second Quarter of 2025
August 8, 2025
·
19 min read
Press Releases
AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
August 8, 2025
·
12 min read
1 of 20
Next
